Avid Bioservices Inc (CDMO)

[nuke661]

Re: Dr. Chabner's reasons for aligning with PPHM - I would think that it would be obvious. The PR release info stated that Dr. Chabner was instrumental in the approval process of Paclitaxel; PR quote: "He has received numerous honors and awards, including the U.S. Public Health Service's Distinguished Service Award for his leadership in the development and approval of paclitaxel (Taxol(R)), a mainstay of current cancer therapy."

PPHM is running two trials of Bavi + Paclitaxel (breast and lung cancer). If Dr. Chabner was a involved in the development and approval of Paclitaxel and Paclitaxel is a mainstay in cancer therapy then it would be no stretch to say that Dr. Chabner's practice uses Paclitaxel as a major therapy regimen. The fact that Bavi+Paclitaxel is showing great promise is all the reason in the world for Dr. Chabner to go in with PPHM to augment and enhance the effectiveness of his practice's treatments.

This certainly seems to SUGGEST to me that Dr. Chabner has a pretty firm belief that Bavi will fit into the mainstay of cancer treatment by proof of its synergies with existing mainstay therapies as evidenced by the India cancer trial results to date. And I'm sure he's seen more of the details than we have.